Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.

Johnson, M D; Campbell, L K; Campbell, R K

Johnson, M D; Campbell, L K; Campbell, R K.

Affiliation

Johnson MD; College of Pharmacy, Washington State University, Spokane 99204, USA. johnsonm@mail.wsu.edu

Ann Pharmacother ; 32(3): 337-48, 1998 Mar.

Article in En | MEDLINE | ID: mdl-9533065

Subject(s)

Chromans/therapeutic use; Diabetes Mellitus/drug therapy; Glucose Intolerance/drug therapy; Hypoglycemic Agents/therapeutic use; Thiazoles/therapeutic use; Thiazolidinediones; Animals; Chromans/chemistry; Chromans/pharmacokinetics; Chromans/pharmacology; Clinical Trials as Topic; Humans; Hypoglycemic Agents/chemistry; Hypoglycemic Agents/pharmacokinetics; Hypoglycemic Agents/pharmacology; Insulin Resistance; Thiazoles/chemistry; Thiazoles/pharmacokinetics; Thiazoles/pharmacology; Troglitazone

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thiazoles / Chromans / Glucose Intolerance / Thiazolidinediones / Diabetes Mellitus / Hypoglycemic Agents Type of study: Clinical_trials / Guideline / Systematic_reviews Limits: Animals / Humans Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 1998 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links